HomeEIGR • NASDAQ
Follow
Eiger Biopharmaceuticals Inc
Previous close
$4.97
Day range
$5.00 - $5.16
Year range
$4.79 - $43.39
Market cap
7.40M USD
Avg Volume
15.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 3.21M | -20.25% |
Operating expense | 20.02M | -31.34% |
Net income | -18.03M | 33.50% |
Net profit margin | -561.86 | 16.60% |
Earnings per share | -12.30 | 33.87% |
EBITDA | -16.85M | 35.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 44.43M | -64.65% |
Total assets | 55.65M | -61.28% |
Total liabilities | 57.26M | -12.50% |
Total equity | -1.60M | — |
Shares outstanding | 1.48M | — |
Price to book | -4.60 | — |
Return on assets | -66.12% | — |
Return on capital | -88.81% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -18.03M | 33.50% |
Cash from operations | -14.55M | 29.21% |
Cash from investing | 19.00M | 82.97% |
Cash from financing | 15.00K | 117.05% |
Net change in cash | 4.52M | 144.02% |
Free cash flow | -8.35M | 24.81% |
About
Founded
2000
Headquarters
Website
Employees
51